高级搜索

一种新型小分子化合物增强PC3细胞的辐射敏感性

Novel Small Compound Sensitizes PC3 Cell Line to Radiation

  • 摘要: 目的 检测小分子化合物8-氧-8H-苊并1,2-b吡咯-9-腈的氨基取代衍生物(S1)对前列腺癌细胞系PC3辐射敏感性的作用。方法 采用流式细胞术分别检测不同剂量X射线和不同浓度S1化合物以及两者联合作用后,PC3细胞凋亡率的变化;采用Western blot方法检测S1作用后不同时间Bcl-2蛋白在PC3细胞中的表达变化。结果 X射线诱导PC3细胞凋亡具有剂量依赖特性,2Gy、5Gy X 射线照射未发现明显的凋亡,10Gy、20Gy照射组有明显的凋亡产生 (P<0.01);S1化合物能够显著诱导PC3细胞凋亡,并具有剂量依赖特性,其中5μmol/L和10μmol/L组凋亡率明显高于对照组(P<0.01);S1作用后2~12h PC3细胞中Bcl-2蛋白表达逐渐减低;S1作用后,分别给予PC3细胞2Gy和8Gy X射线照射,细胞凋亡率明显高于单独照射组和单独S1作用组(P<0.01)。结论 S1能够增强PC3细胞对X射线的敏感性,可望为临床提高前列腺癌放疗效果,降低辐射损伤提供新的治疗方案。

     

    Abstract: Objective To determine the role of the heterocyclic compound 8-oxo-3-thiomorpholino-8H-acenaphtho1,2-b pyrrole-9-carbonitrile (S1) pyrrole-9-carbonitrile (S1) in sensitizing of human prostate cancer cell line PC3 to radiation. Methods Flow cytometry analysis was used to detect the apoptosis ratio of PC3 cells after treated with different dose of X-ray irradiation or different concentration of S1 or combination of them; Bcl-2 protein levels in PC3 cells treated with S1 in different time point was detected by Western blot method. Results The results showed that X-ray could induce apoptosis of PC3 cells with a dose-dependent manner. There was not significant changes in apoptosis of PC3 cells after 2Gy or 5Gy X-ray irradiation, however, there was obviously apoptosis after 10Gy or 20Gy X-ray irradiation (P<0.01). It was also demonstrated that S1 could induce apoptosis ratio change in PC3 cells with a dose-dependent manner. The ratio of apoptosis percentage in 5μmol/L group and 10μmol/L group was significantly higher than that of control group (P<0.01). Bcl-2 protein level was decreased gradually in PC-3 cells treated with S1 for 2 to12h. After treated with S1, PC3 cells were exposed to 2Gy or 8Gy X-ray irradiation, the ratio of apoptosis was markedly elevated compared with irradiation alone group or S1 alone group (P<0.01). Conclusion Our results incated that the small compound S1 could sensitize PC3 cell line to X-rays irradiation. It's a potential new therapeutic method to improve the therapeutic efficiency of human prostate cancers which can decrease radiation-induced lesion.

     

/

返回文章
返回